Nanjing Medlander Medical Technology Co.,Ltd.

SHSE:688273 Stock Report

Market Cap: CN¥2.4b

Nanjing Medlander Medical TechnologyLtd Valuation

Is 688273 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 688273 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 688273 (CN¥23.79) is trading below our estimate of fair value (CN¥26.42)

Significantly Below Fair Value: 688273 is trading below fair value, but not by a significant amount.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for 688273?

Other financial metrics that can be useful for relative valuation.

688273 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue4.2x
Enterprise Value/EBITDA12.6x
PEG Ratio0.5x

Price to Earnings Ratio vs Peers

How does 688273's PE Ratio compare to its peers?

The above table shows the PE ratio for 688273 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average34.6x
301033 Medprin Regenerative Medical Technologies
57.3x44.7%CN¥2.7b
301290 Jiangsu Canopus Wisdom Medical TechnologyLtd
22.3xn/aCN¥2.2b
301515 Sichuan Gangtong Medical Equipment Group
24.2xn/aCN¥2.1b
300562 Guangdong Transtek Medical Electronics
34.5x17.3%CN¥2.1b
688273 Nanjing Medlander Medical TechnologyLtd
25.9x47.8%CN¥2.4b

Price-To-Earnings vs Peers: 688273 is good value based on its Price-To-Earnings Ratio (25.9x) compared to the peer average (34.6x).


Price to Earnings Ratio vs Industry

How does 688273's PE Ratio compare vs other companies in the CN Medical Equipment Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a23.0%
n/an/an/a
No. of CompaniesPE048121620

Fetching data

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a23.0%
n/an/an/a
No more companies

Price-To-Earnings vs Industry: 688273 is good value based on its Price-To-Earnings Ratio (25.9x) compared to the CN Medical Equipment industry average (30.7x).


Price to Earnings Ratio vs Fair Ratio

What is 688273's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

688273 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio25.9x
Fair PE Ratio34.9x

Price-To-Earnings vs Fair Ratio: 688273 is good value based on its Price-To-Earnings Ratio (25.9x) compared to the estimated Fair Price-To-Earnings Ratio (34.9x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.


Discover undervalued companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.